Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1203-1205, 2000;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dibbelt, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dibbelt, L.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:1203-1205.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Does Trisialo-Transferrin Provide Valuable Information for the Laboratory Diagnosis of Chronically Increased Alcohol Consumption by Determination of Carbohydrate-deficient Transferrin?

Leif Dibbelt1

1 Institute of Clinical Chemistry, Medical University, D-23538 Luebeck, Germany

Transferrin, the principal iron transporter in human serum, is a glycoprotein bearing asparagine-linked polysaccharides (1). Because of differences in the glycan structure, several transferrin isoforms can be found in normal serum, the most prominent one containing two biantennary complex-type glycans with a total number of four negatively charged terminal sialic acid residues (2)(3). It has been known for >20 years that chronically increased consumption of ethanol affects the glycosylation pattern of serum transferrin, producing a higher proportion of transferrin isoforms that lack terminal sialic acid residues and probably other parts of the glycan structure and thus are referred to as carbohydrate-deficient transferrin (CDT) (3)(4)(5). Originally, CDT was defined as the sum of transferrin isoforms containing two or fewer two sialic acid residues (corresponding to pI values >=5.7), and this definition has likewise been applied to the evaluation of CDT as a sensitive and specific laboratory marker of alcoholism (4)(5). During the last few years, however, commercial kits were launched that measure an operationally defined CDT fraction that in addition to asialo-, monosialo-, and disialo-transferrin also includes at least in part the trisialo-transferrin isoform (6). The inclusion of trisialo-transferrin in the definition of CDT has been claimed to improve the detection of chronic alcohol consumption (7), but the diagnostic significance of the trisialo-transferrin concentration remains unclear (8). Therefore, I reexamined our data from routine determinations of CDT in human serum in search of a quantitative relationship between the various isotransferrins resolved by our method.

In our laboratory, determination of absolute and relative CDT concentrations in serum samples is routinely performed by HPLC on Mono Q® anion exchanger (Amersham Pharmacia Biotech), using the method described by Jeppson et al. (9) with minor modifications (10). This method separates at least four isotransferrin fractions in normal human serum exhibiting pI values of 5.7 (disialo-transferrin), 5.6 (trisialo-transferrin), 5.4 (tetrasialo-transferrin), and 5.2 (pentasialo-transferrin). In serum from patients with chronically increased alcohol consumption, the portion of disialo-transferrin usually is increased and another peak at pI 5.9 (asialo-transferrin) appears in the chromatogram that is not detected in serum from healthy abstinent people. CDT is calculated as the sum of asialo and disialo-transferrin (monosialo-transferrin usually is not detected by HPLC because of its low concentration) and is reported in relative concentration units, i.e., as a percentage of total transferrin. Baseline integration is applied to the HPLC chromatograms (11) instead of the valley-to-valley integration described by Jeppson et al. (9) and Renner and Kanitz (10); with this modification our local reference range extends to 2.4% CDT, which is significantly higher than the cutoff values reported in the literature for valley-to-valley integration (8)(9)(12). Statistical analysis of data was performed using SPSS for Windows, release 6.1.

Between September 1, 1997 and August 31, 1998, our laboratory received 887 patient samples for routine analysis of CDT. Requests for these CDT determinations were all made for laboratory confirmation of suspected alcoholism or follow-up of its therapy; they came mainly from the clinics of psychiatry (40%), neurology (18%), internal medicine (18%), and anesthesiology (9%), whereas the remaining 15% stemmed from ~10 different institutions. Results of 17 samples indicated a heterozygous expression of genetic transferrin variants (16 allelic variants of the B type and 1 allelic D variant) that prevented reliable calculation of CDT. When the latter results were excluded, there remained 870 chromatograms that had been routinely evaluated for CDT. In 706 samples, the relative CDT concentration was at or below the upper limit of our reference range, whereas 164 samples exhibited increased CDT concentrations (>2.4%). For at least 116 of the latter samples, the increased CDT concentration could be retrospectively explained by heavy drinking according to information given by the patients or by markedly increased blood ethanol concentrations measured on patients’ admissions.

In addition to the asialo- and disialo-transferrin concentrations routinely used for calculation of the CDT concentration, I also extracted the relative concentrations of trisialo- and tetrasialo-transferrin as well as the total concentration of isotransferrins with higher numbers of terminal sialic acid residues (i.e., pentasialo- and hexasialo-transferrin) from all chromatograms. The relative disialo- and trisialo-transferrin concentrations measured in the complete series of samples are shown in Fig. 1 . From this comparison, it clearly can be seen that high disialo-transferrin concentrations are not accompanied in general by high trisialo-transferrin concentrations. When the results were grouped according to either normal (<=2.4%) or increased (>2.4%) CDT concentration attributable to heavy drinking, I obtained the relative concentration ranges; the 5th, 50th, and 95th percentiles; and the means ± SD for the various isotransferrin fractions, as summarized in Table 1 . Whereas the disialo-transferrin concentrations obviously differed significantly between the two groups (range, 0.00–2.43% vs 2.47–19.7%), the corresponding trisialo-transferrin concentrations were almost identical (range, 1.16–13.0% vs 1.58–8.88%). Statistical analysis revealed a rather low correlation (r = 0.194) between the concentrations of disialo- and trisialo-transferrin in samples exhibiting normal CDT values, but no correlation (r = -0.038) in samples showing increased CDT concentrations attributable to alcohol intake (Table 1 ). In the group exhibiting normal CDT values, correlation was highest between tetrasialo- and pentasialo-/hexasialo-transferrin (r = -0.821), indicating that highly sialylated isotransferrins are preferably produced at the expense of the tetrasialo-transferrin fraction. In the group of samples with increased CDT values attributable to heavy drinking, strong correlations were obtained for disialo- and asialo-transferrin (r = 0.806), disialo- and tetrasialo-transferrin (r = -0.845), and asialo- and tetrasialo-transferrin (r = -0.722). These observations agree well with the assumption that it is not the terminal sialylation of otherwise complete glycan moieties that is impaired by chronically increased intake of alcohol but rather the formation of one or both of the entire glycan chains (3)(13).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Comparison of relative concentrations of disialo- and trisialo-transferrin in human serum as derived from routine analysis of CDT by HPLC (n = 870).

• indicates increased disialo-transferrin concentrations attributable to heavy drinking (n = 116).


View this table:
[in this window]
[in a new window]
 
Table 1. Correlation coefficients (r) obtained from statistical analysis of relative concentrations of the various isotransferrins separated by HPLC in sera exhibiting normal (top) and increased CDT concentrations attributable to high alcohol intake (bottom).

It is still unknown which physiological or pathological mechanisms regulate the portion of trisialo-transferrin in relation to other isotransferrins. Our data, however, clearly demonstrate that increased relative concentrations of disialo- and asialo-transferrin attributable to increased consumption of alcohol are not associated in general with increased trisialo-transferrin concentrations. Because trisialo-transferrin is obviously of no diagnostic value, I strongly recommend not including this isotransferrin in the CDT fraction measured for laboratory diagnosis of alcoholism.


Acknowledgments

I am most grateful to R. Albrecht-Groos, K. Blöcker, A. Blunk, A. Boldt, B. Brede, B. Ermert, M. Gierke, B. Gütschow, R. Hesemeyer, H. Hinz, A. Niemeier, and K. Stratmann for expert work in the routine HPLC analysis of CDT.


Footnotes

fax 49-451-5004849


References

  1. de Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;190:1-46. [ISI][Medline] [Order article via Infotrieve]
  2. Spik G, Bayard B, Fournet B, Strecker G, Bouquelet S, Montreuil J. Studies on glyco-conjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett 1975;50:296-299. [ISI][Medline] [Order article via Infotrieve]
  3. Landberg E, Påhlsson P, Lundblad A, Arnetorp A, Jeppsson JO. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Commun 1995;210:267-274. [ISI][Medline] [Order article via Infotrieve]
  4. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37:2029-2037. [Abstract/Free Full Text]
  5. Arndt T. Kohlenhydrat-defizientes Transferrin (CDT): die derzeit spezifischste Kenngrösse chronischen Alkoholmissbrauchs. J Lab Med 1999;23:392-406.
  6. Bean P, Liegmann K, Løvli T, Westby C, Sundrehagen E. Semiautomated procedures for evaluation of carbohydrate-deficient transferrin in the diagnosis of alcohol abuse. Clin Chem 1997;43:983-989. [Abstract/Free Full Text]
  7. Heggli DE, Aurebekk A, Granum B, Westby C, Løvli T, Sundrehagen E. Should tri-sialo-transferrins be included when calculating carbohydrate-deficient transferrin for diagnosing elevated alcohol intake?. Alcohol Alcohol 1996;31:381-384. [Abstract/Free Full Text]
  8. Renner F, Stratmann K, Kanitz RD, Wetterling T. Determination of carbohydrate-deficient transferrin and total transferrin by HPLC: diagnostic evaluation. Clin Lab 1997;43:955-964.
  9. Jeppson JO, Kristensson H, Fimiani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem 1993;39:2115-2120. [Abstract]
  10. Renner F, Kanitz RD. Quantification of carbohydrate-deficient transferrin by ion-exchange chromatography with an enzymatically prepared calibrator. Clin Chem 1997;43:485-490. [Abstract/Free Full Text]
  11. Niemeier A, Blöcker K, Dibbelt L. Relative and absolute CDT concentrations in sera from anemic patients measured by commercial immunoassays following miniaturized column chromatography and by high performance liquid chromatography. Clin Lab 1999;45:371-376.
  12. Simonsson P, Lindberg S, Alling C. Carbohydrate-deficient transferrin measured by high-performance liquid chromatography and CDTectTM immunoassay. Alcohol Alcohol 1996;31:397-402. [Abstract/Free Full Text]
  13. Henry H, Froehlich F, Perret R, Tissot J-D, Eilers-Messerli B, Lavanchy D, et al. Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I. Clin Chem 1999;45:1408-1413. [Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. B. Whitfield, V. Dy, P. A.F. Madden, A. C. Heath, N. G. Martin, and G. W. Montgomery
Measuring Carbohydrate-Deficient Transferrin by Direct Immunoassay: Factors Affecting Diagnostic Sensitivity for Excessive Alcohol Intake
Clin. Chem., July 1, 2008; 54(7): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, A. Husa, and J.-O. Jeppsson
Improved HPLC Method for Carbohydrate-deficient Transferrin in Serum
Clin. Chem., November 1, 2003; 49(11): 1881 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry
Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption
Clin. Chem., March 1, 2003; 49(3): 440 - 449.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
C. Flahaut, J.C. Michalski, T. Danel, M.H. Humbert, and A. Klein
The effects of ethanol on the glycosylation of human transferrin
Glycobiology, March 1, 2003; 13(3): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Tagliaro, F. Bortolotti, R. M. Dorizzi, M. Marigo, J. R. Delanghe, B. Wuyts, and M. L. De Buyzere
Caveats in Carbohydrate-deficient Transferrin Determination Drs. Delanghe, Wuyts, and De Buyzere respond:
Clin. Chem., January 1, 2002; 48(1): 208 - 209.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
U. Turpeinen, T. Methuen, H. Alfthan, K. Laitinen, M. Salaspuro, and U.-H. Stenman
Comparison of HPLC and Small Column (CDTect) Methods for Disialotransferrin
Clin. Chem., October 1, 2001; 47(10): 1782 - 1787.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
A. Helander, M. Fors, and B. Zakrisson
STUDY OF AXIS-SHIELD NEW %CDT IMMUNOASSAY FOR QUANTIFICATION OF CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IN SERUM
Alcohol Alcohol., September 1, 2001; 36(5): 406 - 412.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, G. Eriksson, H. Stibler, and J.-O. Jeppsson
Interference of Transferrin Isoform Types with Carbohydrate-deficient Transferrin Quantification in the Identification of Alcohol Abuse
Clin. Chem., July 1, 2001; 47(7): 1225 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Arndt
Carbohydrate-deficient Transferrin as a Marker of Chronic Alcohol Abuse: A Critical Review of Preanalysis, Analysis, and Interpretation
Clin. Chem., January 1, 2001; 47(1): 13 - 27.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dibbelt, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dibbelt, L.
Related Collections
Right arrow Proteomics and Protein Markers


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS